3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1635
Carcinoma, Renal Cell
504
Urinary Bladder Neoplasms
462
Carcinoma, Transitional Cell
233
Breast Neoplasms
227
Kidney Neoplasms
218
Neoplasms
194
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
171
Ovarian Neoplasms
162
Melanoma
162
Neoplasm Metastasis
144
Lung Neoplasms
128
Non-Muscle Invasive Bladder Neoplasms
107
Pancreatic Neoplasms
102
Stomach Neoplasms
101
Uterine Cervical Neoplasms
92
Squamous Cell Carcinoma of Head and Neck
86
Endometrial Neoplasms
83
Sarcoma
76
Carcinoma, Hepatocellular
76
Esophageal Neoplasms
72
Head and Neck Neoplasms
69
Adenocarcinoma
67
Triple Negative Breast Neoplasms
66
Colonic Neoplasms
53
Testicular Neoplasms
52
Disease
47
Wilms Tumor
46
Urologic Neoplasms
46
Interventions
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Castrate Resistance Prostate Cancer
×
Genitourinary
×
1 year
×
Clear all
NCT06927635
2025-09-05
SECURE
University Health Network, Toronto
Phase 2
Recruiting
75 enrolled